These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9212100)

  • 1. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase.
    Bérard AM; Föger B; Remaley A; Shamburek R; Vaisman BL; Talley G; Paigen B; Hoyt RF; Marcovina S; Brewer HB; Santamarina-Fojo S
    Nat Med; 1997 Jul; 3(7):744-9. PubMed ID: 9212100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
    Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
    APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
    Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
    J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
    Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
    Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
    Furbee JW; Parks JS
    Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis.
    Mehlum A; Gjernes E; Solberg LA; Hagve TA; Prydz H
    APMIS; 2000 May; 108(5):336-42. PubMed ID: 10937770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT.
    Furbee JW; Francone O; Parks JS
    J Lipid Res; 2001 Oct; 42(10):1626-35. PubMed ID: 11590219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
    Furbee JW; Sawyer JK; Parks JS
    J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.
    Hoeg JM; Vaisman BL; Demosky SJ; Meyn SM; Talley GD; Hoyt RF; Feldman S; Bérard AM; Sakai N; Wood D; Brousseau ME; Marcovina S; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1996 Feb; 271(8):4396-402. PubMed ID: 8626790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
    Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice.
    Dugi KA; Vaisman BL; Sakai N; Knapper CL; Meyn SM; Brewer HB; Santamarina-Fojo S
    J Lipid Res; 1997 Sep; 38(9):1822-32. PubMed ID: 9323591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.